AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Merck & Co., Inc. Director's Dealing 2022

Jul 26, 2022

284_dirs_2022-07-26_a1355df9-5a31-4222-9940-352a4c73980a.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2022-07-18

Reporting Person: Romanelli Joseph (President, Human Health Int?l)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	25284.325	Direct

Footnotes

F1: Holdings include shares acquired in dividend reinvestment transactions.